Diversity, Equity and Inclusion:
All in for Diversity, Equity & Inclusion at Sanofi
We have around 100,000 (exact figure in 2021 is 95,442) employees with over 142 nationalities between us, but diversity on its own is not enough. That’s why we work constantly to ensure our workplace is also inclusive, where everyone can be their true selves, comfortable to speak up and brave enough to speak out. Building such an environment also directly influences and impacts how we engage with patients and customers, as well as with the communities where we work.
Building Responsible Leadership
By 2025, 50% of our senior leaders and 40% of our executives will be women. The other diversity strands we’re focusing on are age, race, ethnicity, faith, disability, and the LGBTQIA+ community. We’re striving to ensure they are equally represented in our leadership and teams across Sanofi and will set key performance indicators that are locally relevant in each country. Other diversity strands that are not necessarily protected characteristics by law in certain countries, such as socio-economic background, are also considered in our diversity and inclusion strategy.
We have a Global Supplier Diversity program in place to increase the inclusion of historically disadvantaged or under-represented groups in our sourcing processes. We have a partnership with WeConnect International to increase our collaboration and engagement with women-owned businesses, and support women’s economic empowerment. On International Women’s Day March 8, 2022, we made a public commitment to double our woman-owned business spend by 2025 and spend over €1.5 billion with small and diverse businesses by 2025.
Sanofi has committed to achieving gender balance in management by 2025, by reaching 40% of women top executives and 50% of women senior leaders. As of March 2022, we have 35.1% of our top executives and 40.4% of our senior leaders who are women. To facilitate our efforts, we have implemented gender neutral parental leave globally, regularly monitor our efforts through dashboards and introduced awareness programs for managers.
Sanofi has committed to monitoring and reducing its environmental impact through its strategy, “Planet Mobilization,” to limit the impact on the environment at every stage of the product lifecycle: from the raw materials we use in our medicines, devices and services to their potential end-of-life impact on human health and the environment.
• Reduce GHG emissions from Sanofi activities by 55% and from scope 3 by 14% by 2030 (2019 base year)
• Reach 100% renewable electricity across all global operations by 2030 and
• Achieve a carbon neutral car fleet by 2030.
Improve the environmental profile of our products with eco-design approach for all new products by 2025 and by ending the use of plastic in blister packs for all our vaccines by 2027. This is a truly complex industrial endeavor that will address the problem of plastic waste in the environment.
2. Limit our environmental footprint and adopt circular solutions
3. Improve environmental profile of our products